Page 63 - Lipids News Today

An investigational drug targets the adipocyte to treat insulin resistance. The drug restores glucose absorption in animal models and could provide a new approach to type 2 diabetes.

A Mendelian randomization study appears to exonerate very low LDL-C but not therapies from altering cognition.

Patients prescribed medicines for asymptomatic conditions are far less likely to be adherent than those prescribed medicines for symptomatic conditions, according to a retrospective analysis.

USA: People who consume high amount of sugar-sweetened beverages (sodas and fruit drinks) may be at higher cardiometabolic risk, says a recent study published in The Journal of Nutrition. The study...

One of the hallmarks of Alzheimer's disease is a reduction in the firing of some neurons in the brain, which contributes to the cognitive decline that patients experience.

Support from the national government for irrigation development will be crucial even with the upcoming devolution of functions to local government units, given limitations on local governments’ capability, according to state think tank Philippine Institute for Development Studies.

Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for renal safety in such cases, experts say.

Skin swabs are "surprisingly effective" at identifying Covid-19 infection, according to new research from the University of Surrey, offering a route to a non-invasive future for Covid-19 testing.

People with gut disorders may be at greater risk of developing Alzheimer's Disease (AD).

Similar benefits were seen with low, moderate, and high statin doses, as well as in cases of both mild and severe acute pancreatitis.